Understanding the Effect of Hydroxypropyl‐β‐Cyclodextrin on Fenebrutinib Absorption in an Itraconazole–Fenebrutinib Drug–Drug Interaction Study-Reference-Cited by-同舟云学术

Understanding the Effect of Hydroxypropyl‐β‐Cyclodextrin on Fenebrutinib Absorption in an Itraconazole–Fenebrutinib Drug–Drug Interaction Study

Published:2020-07-18 Issue:6 Volume:108 Page:1224-1232
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Durk Matthew R.¹,Jones Nicholas S.²,Liu Jia³,Nagapudi Karthik³,Mao Chen³,Plise Emile G.¹,Wong Susan¹,Chen Jacob Z.¹,Chen Yuan¹,Chinn Leslie W.²,Chiang Po‐Chang³

Affiliation:

1. Department of Drug Metabolism and Pharmacokinetics Genentech, Inc. South San Francisco California USA

2. Department of Clinical Pharmacology Genentech, Inc. South San Francisco California USA

3. Department of Small Molecule Pharmaceutical Sciences Genentech, Inc. South San Francisco California USA

Funder

Genentech

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1943

Reference29 articles.

1. Cyclodextrin Drug Carrier Systems

2. Best practices for the use of itraconazole as a replacement for ketoconazole in drug-drug interaction studies

3. Discovery of GDC-0853: A Potent, Selective, and Noncovalent Bruton’s Tyrosine Kinase Inhibitor in Early Clinical Development

4. Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Volunteers Treated With GDC‐0853, a Selective Reversible Bruton's Tyrosine Kinase Inhibitor

5. Evaluating the Utility of Canine Mdr1 Knockout Madin-Darby Canine Kidney I Cells in Permeability Screening and Efflux Substrate Determination

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of itraconazole, a strong CYP3A4 inhibitor, on the pharmacokinetics of the first‐in‐class ACKR3/CXCR7 antagonist, ACT‐1004‐1239;Clinical and Translational Science;2024-07

2. QbD Assisted Systematic Review for Optimizing the Selection of PVP as a Ternary Substance in Enhancing the Complexation Efficiency of Cyclodextrins: a Pilot Study;AAPS PharmSciTech;2024-06-11

3. Cyclodextrin‐based nanosponges as promising carriers for active pharmaceutical ingredient;Journal of Biochemical and Molecular Toxicology;2023-11-30

4. Regulatory Considerations in Metabolism‐ and Transport‐Based Drug Interactions;Oral Bioavailability and Drug Delivery;2023-10-10

5. Leveraging the use of in vitro and computational methods to support the development of enabling oral drug products: An InPharma commentary;European Journal of Pharmaceutical Sciences;2023-09